Adding targeted radiation to chemotherapy prior to surgery may offer better control of pancreatic tumors—potentially reducing ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

As part of a clinical trial, the National Center for Tumor Diseases (NCT/UCC) Dresden is now offering patients with ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, autoimmune disorders like Type 1 diabetes and rare diseases like cystic ...

A new mRNA vaccine could prevent pancreatic cancer from returning — potentially for the long haul. In a small clinical trial, some patients who received the vaccine remained cancer-free for more ...

U.S. mortality rates, meanwhile, are on the upswing. But promising results from a small clinical trial for an mRNA pancreatic cancer vaccine are fueling new rays of hope.

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 clinical trial results reveal an immune response ...

“But mRNA vaccines are one way to train [immune systems] to detect, fight and kill cancer cells.” Raufi described the vaccine as a form of personalized treatment for pancreatic cancer patients.

FRIDAY, Feb. 21, 2025 (HealthDay News) -- Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial ...